June 17, 2020 / 12:32 PM / 2 months ago

BRIEF-Exagen Enters Into An Exclusive Worldwide License Deal With Ohio State Innovation Foundation

June 17 (Reuters) - Exagen Inc:

* EXAGEN INC - ENTERED INTO AN EXCLUSIVE WORLDWIDE LICENSE AGREEMENT WITH OHIO STATE INNOVATION FOUNDATION

* EXAGEN INC - EXCLUSIVE LICENSE AGREEMENT FOR A NOVEL, RULE-IN, BLOOD TEST TO SUPPORT DIAGNOSIS OF FIBROMYALGIA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below